DUPILUMAB IMPROVES QUALITY OF LIFE IN CAREGIVERS OF CHILDREN WITH UNCONTROLLED MODERATE-TO-SEVERE ASTHMA: LIBERTY ASTHMA VOYAGE STUDY

被引：0
|
作者：
Fiocchi, A. G. [1 ]
Phipatanakul, W. [2 ]
Durrani, S. [3 ]
Cole, J. [4 ]
Msihid, J. [5 ]
Lederer, D. J. [6 ]
Hardin, M. [7 ]
Zhang, Y. [6 ]
Khan, A. H. [5 ]
机构：
[1] Bambino Gesu Childrens Hosp IRCCS, Rome, RM, Italy
[2] Harvard Med Sch, Boston Childrens Hosp, Boston, MA 02115 USA
[3] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA
[4] OK Clin Res, Edmond, OK USA
[5] Sanofi, Chilly Mazarin, France
[6] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[7] Sanofi, Cambridge, MA USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
P38
引用
收藏
页码：S294 / S295
页数：3
相关论文
共 50 条
  • [31] Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma
    Corren, Jonathan
    Castro, Mario
    O'Riordan, Thomas
    Hanania, Nicola A.
    Pavord, Ian D.
    Quirce, Santiago
    Chipps, Bradley E.
    Wenzel, Sally E.
    Thangavelu, Karthinathan
    Rice, Megan S.
    Harel, Sivan
    Jagerschmidt, Alexandre
    Khan, Asif H.
    Kamat, Siddhesh
    Maroni, Jaman
    Rowe, Paul
    Lu, Yufang
    Amin, Nikhil
    Pirozzi, Gianluca
    Ruddy, Marcella
    Graham, Neil M. H.
    Teper, Ariel
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (02): : 516 - 526
  • [32] Dupilumab in moderate-to-severe asthma
    Mellis, Craig
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2022, 58 (01) : 209 - 209
  • [33] Effect of dupilumab on asthma control and asthma-related quality of life in patients with uncontrolled, moderate-to-severe type 2 asthma: TRAVERSE OLE study
    Busse, W.
    Pavord, I. D.
    Corren, J.
    Menzies-Gow, A.
    Heffler, E.
    Msihid, J.
    Siddiqui, S.
    Lederer, D. J.
    Hardin, M.
    Zhang, Y.
    Khan, A. H.
    Jacob-Nara, J. A.
    Deniz, Y.
    Rowe, P. J.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [34] Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma recruited from Japanese centers in the phase 3 LIBERTY ASTHMA TRAVERSE study
    Tohda, Yuji
    Nakamura, Yoichi
    Fujisawa, Takao
    Ebisawa, Motohiro
    Msihid, Jerome
    Djandji, Michel
    Ortiz, Benjamin
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Rowe, Paul J.
    Ishida, Masato
    Arima, Kazuhiko
    ALLERGOLOGY INTERNATIONAL, 2023, 72 (01) : 89 - 99
  • [35] Dupilumab Improved Lung Function in Patients with Uncontrolled, Moderate-to-Severe Asthma Despite Exacerbation Events During the LIBERTY ASTHMA QUEST Study
    Rabe, K. F.
    Castro, M.
    Wenzel, S. E.
    Corren, J.
    Pavord, I. D.
    Katelaris, C.
    Tohda, Y.
    Rice, M. S.
    Lu, Y.
    Rowe, P.
    Staudinger, H. W.
    Amin, N.
    Akinlade, B.
    Graham, N. M. H.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [36] Dupilumab Produces Rapid and Sustained Improvements in Asthma-Related Symptoms in Patients with Uncontrolled, Moderate-To-Severe Asthma from the LIBERTY ASTHMA QUEST Study
    Corren, J.
    Castro, M.
    Guillonneau, S.
    Chao, J.
    Amin, N.
    Pirozzi, G.
    Graham, N. M.
    Teper, A.
    Khan, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [37] DUPILUMAB REDUCES BIOMARKERS OF TYPE 2 INFLAMMATION IN CHILDREN WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA
    Bacharier, L.
    Maspero, J.
    Katelaris, C.
    Fiocchi, A.
    Liu, D.
    Lederer, D.
    Hardin, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S33 - S33
  • [38] DUPILUMAB REDUCES EXACERBATIONS AND IMPROVES LUNG FUNCTION IN UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA PATIENTS REGARDLESS OF PRIOR EXACERBATION HISTORY IN THE PHASE 3 LIBERTY ASTHMA QUEST STUDY
    Pavord, I.
    Ford, L. B.
    Corren, J.
    Kuna, P.
    Dong, Q.
    Staudinger, H.
    Maroni, J.
    Rowe, P.
    Rout, R.
    Amin, N.
    Akinlade, B.
    Graham, N. M. H.
    Teper, A.
    THORAX, 2018, 73 : A121 - A122
  • [39] DUPILUMAB IN MODERATE-TO-SEVERE ASTHMA: GOOD OUTCOMES IN CHILDREN
    Nuttall, Amy G.
    THORAX, 2022, 77 (04) : 424 - 424
  • [40] Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma with fungal sensitization
    Corren, Jonathan
    Hanania, Nicola A.
    Busse, William W.
    Sher, Lawrence D.
    Altincatal, Arman
    Hardin, Megan
    Mannent, Leda P.
    Amin, Nikhil
    Lederer, David J.
    Soler, Xavier
    Jacob-Nara, Juby A.
    Rowe, Paul J.
    Deniz, Yamo
    CLINICAL AND EXPERIMENTAL ALLERGY, 2023, 53 (10): : 1020 - 1030
12345